PERMANENT AWARD EVIDENCE

Radiopharmaceuticals Treatment of Prostate Cancer (Xofigo)

United Lincolnshire Teaching Hospitals NHS Trust · published 11 Mar 2026. This page preserves the identifiers and current held fields for one Contracts Finder release; it is not an invoice, performance assessment or complete contract history.

Open official source ↗More from this buyer

Contracts Finder release IDc2e4b524-eeed-48f4-9002-d198f4c863da-888172

Open Contracting ID (OCID)ocds-b5fd17-024e1aea-aa3c-43bc-9688-4a07655b63be

Buyer identifierGB-CFS-303237

Release typeaward

PUBLISHED COMMERCIAL FIELDS

Values stay separate.

A tender estimate and an award value answer different questions. Neither is treated as cash paid.

Award value: £105,600
Tender value: £105,600
Procurement method: Single tender action (below threshold)
Category: goods
CPV: 33000000
Delivery: Not stated

PUBLISHED DESCRIPTION

What the notice says

Provision of Xofigo, drug to treat Prostate Cancer

Tender statuscomplete

STAGE-DATE LEDGER

Reported dates, without an invented lifecycle.

The current projection contains one award release, not a verified chain of planning, tender, award, contract and modification records. Dates are shown in source-field order and are not silently repaired.

01Notice publishedPublication timestamp on the held release11 Mar 2026
02Tender period endsTender-period field as published17 Dec 2025
03Contract startsContract-period field as published31 Dec 2025
04Contract endsContract-period field as published30 Dec 2027

SUPPLIER EVIDENCE

Published names and exact identifiers

A company profile appears only when this release carries a usable company number. Name-only suppliers remain name-only.

Published name only

Bayer Public Limited Company

No legal entity is inferred from this supplier name.

SOURCE

Contracts Finder release

Published 11 Mar 2026 · held through the daily award projection · Open Government Licence v3.0.

Inspect the official JSON release ↗